Tumor-Derived Complement C3 as a Therapeutic Target in STK11 Mutant Non-Small Cell Lung Cancer

被引：0
|
作者：
Yau, E. [1 ]
Suzuki, S. [1 ]
Kandar, B. [1 ]
Ting, C. [1 ]
Giridharan, T. [1 ]
Stokolosa, A. [1 ]
Khan, A. N. [1 ]
Segal, B. [1 ]
机构：
[1] Roswell Park Comprehens Canc Ctr, Buffalo, NY USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OA18.04
引用
收藏
页码：S86 / S86
页数：1
相关论文
共 50 条
  • [1] Tumor-derived complement C3 is overexpressed in STK11 mutant non-small cell lung cancer and contributes to an immunosuppressive tumor microenvironment in a syngeneic mouse model
    Suzuki, Sora
    Ting, Catrina
    Kandar, Bojidar
    Chen, Te-An
    Khan, Anm Nazmul
    Giridharan, Thejaswini
    Segal, Brahm
    Yau, Edwin H.
    CANCER RESEARCH, 2024, 84 (06)
  • [2] Immunogenomic analysis identifies the complement pathway as a therapeutic target in STK11 mutant non-small cell lung cancer
    Yau, Edwin H.
    Kandar, Bojidar
    Deng, Lei
    Chen, Te-An
    Bshara, Wiam
    Glenn, Sean
    Pabla, Sarabjot
    Papanicolau-Sengos, Antonios
    Nesline, Mary
    Chen, Hongbin
    Early, Amy
    Morrison, Carl
    Dy, Grace
    CANCER RESEARCH, 2022, 82 (12)
  • [3] Identification of Immunotherapy Targets in STK11 Mutant Non-Squamous Non-Small Cell Lung Cancer
    Yau, E.
    Glenn, S.
    Papinicalou-Sengos, A.
    Nesline, M.
    Morrison, C.
    Dy, G.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S442 - S442
  • [4] Clinical immune and genomic profiling of STK11 mutant non-squamous non-small cell lung cancer
    Yau, Edwin
    Pabla, Sarabjot
    Glenn, Sean
    Papanicolau-Sengos, Antonios
    Nesline, Mary
    Dy, Grace
    Morrison, Carl
    CANCER RESEARCH, 2020, 80 (16)
  • [5] Role of STK11 in ALK-positive non-small cell lung cancer
    Zhou, Wen
    Yan, Lu-Da
    Yu, Zhi-Qiong
    Li, Na
    Yang, Yong-Hua
    Wang, Meng
    Chen, Yuan-Yuan
    Mao, Meng-Xia
    Peng, Xiao-Chun
    Cai, Jun
    ONCOLOGY LETTERS, 2022, 23 (06)
  • [6] STK11 is a Potential Therapeutic and Prognostic Biomarker and Correlates with Immune Infiltrates in Non-Small Cell Lung Cancer
    Bensalim, Imane
    Boustany, Youssra
    El Faqer, Abdelmoiz
    Laraqui, Abdelilah
    Belkadi, Bouchra
    EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY, 2024, 8 (03): : 358 - 370
  • [7] Unraveling the Role of STK11/LKB1 in Non-small Cell Lung Cancer
    Sumbly, Vikram
    Landry, Ian
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (01)
  • [8] Tumor-derived complement is required for tumor growth in syngeneic murine STK11-mutant lung adenocarcinoma
    Suzuki, Sora
    Khan, A. N. M. Nazmul
    Giridharan, Thejaswini
    Kandar, Bojidar
    Ting, Catrina
    Stokolosa, Anna
    Segal, Brahm
    Yau, Edwin
    IMMUNOBIOLOGY, 2023, 228 (05) : 25 - 25
  • [9] Association of NEDD9 Expression and Survival of Patients with KRAS Mutant and STK11 Mutant Non-Small Cell Lung Cancer (KRASMUT/STK11MUT-NSCLC)
    Judd, J.
    Gandhi, N.
    Xiu, J.
    Deneka, A.
    Khan, H.
    Karim, N. A.
    Liu, S. V.
    Naqash, A. R.
    Borghaei, H.
    Golemis, E.
    Hemenway, G.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S168 - S169
  • [10] Multi-omics Analysis of Immune Determinants of STK11 in Non-Small Cell Lung Cancer
    Alhushki, S. K.
    Al-Muhtaseb, A.
    Abushukair, H.
    Abulrous, F.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S442 - S443
12345